| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.5 |